Skip to main content
eScholarship
Open Access Publications from the University of California

Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.

  • Author(s): Galpern, Wendy R
  • Corrigan-Curay, Jacqueline
  • Lang, Anthony E
  • Kahn, Jeffrey
  • Tagle, Danilo
  • Barker, Roger A
  • Freeman, Thomas B
  • Goetz, Christopher G
  • Kieburtz, Karl
  • Kim, Scott YH
  • Piantadosi, Steven
  • Comstock Rick, Amy
  • Federoff, Howard J
  • et al.

Published Web Location

http://www.sciencedirect.com/science/article/pii/S1474442212700649
No data is associated with this publication.
Abstract

There have been several recent scientific advances in gene-based and cell-based therapies that might translate into novel therapeutic approaches for neurodegenerative disorders. Such therapies might need to be directly delivered into the CNS, and complex scientific and ethical assessment will be needed to determine whether a sham neurosurgical arm should be included in clinical trials assessing these agents. We have developed a framework of points for investigators to consider when designing trials that involve direct delivery of a therapeutic agent to the CNS. The inclusion of a sham neurosurgical arm will be guided in part by the objectives of the clinical study (preliminary safety, optimisation, and feasibility vs preliminary efficacy vs confirmatory efficacy) and the need to minimise bias and confounds. Throughout the clinical development process, the perspectives of researchers, ethicists, and patients must be considered, and risks should be minimised whenever possible in a manner that is consistent with good trial design.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item